Emtansine is a chemotherapy drug ... Targeting cancer cells can help prevent some side effects that traditional chemotherapy can cause. Can Kadcyla cause long-term side effects?

Side effects, Beck explained, can be gastrointestinal or can include ... Compared to another antibody-drug conjugate, Kadcyla (ado-trastuzumab emtansine), Enhertu has been shown, Beck said, to result ...

If you have certain side effects, you may have to have to change ... Enhertu with another ADC that targets HER2, ado-trastuzumab emtansine (Kadcyla). Enhertu worked better in treating breast ...

The antibody-drug conjugate trastuzumab emtansine (trade name ... "health-related quality of life" and "serious or severe side effects" together provide an indication of a major added benefit.

FDA Approves Genentech's Kadcyla (Ado-Trastuzumab Emtansine), the First Antibody ... There are possible serious side effects of Kadcyla. Patients must contact their doctor right away if they ...

The introduction of Tukysa to Kadcyla emtansine significantly improved progression-free ... Of the 231 patients evaluable for safety in the Tukysa arm, any-grade treatment-emergent side effects ...

Each cycle is 3 weeks long. You can have up to 14 cycles of treatment (42 weeks) as long as it is helping and the side effects aren’t too bad. You have trastuzumab emtansine as a drip into a vein. If ...